Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Radiological Physics and Technology, published by SPRINGER JAPAN KK, is a prominent journal that serves as a crucial resource in the multidisciplinary fields of medicine and radiation sciences. With an ISSN of 1865-0333 and an E-ISSN of 1865-0341, the journal has been converging impactful research from 2008 to 2024. It holds a commendable position in academic rankings, currently classified in Q2 in Physical Therapy, Sports Therapy and Rehabilitation and Radiation, along with Q3 for Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging. The journal is well-regarded in the academic community, reflected in its Scopus rankings that place it in the upper tiers of its respective categories. Although it currently does not offer Open Access, Radiological Physics and Technology remains a pivotal publication for researchers, academics, and practitioners seeking to advance knowledge and foster innovation in radiological science. Its commitment to disseminating high-quality research ensures its continued relevance and importance within these fields.

Brachytherapy, published by ELSEVIER SCIENCE INC, serves as a pivotal journal in the realms of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1538-4721 and an E-ISSN of 1873-1449, the journal disseminates cutting-edge research and advancements from 2002 to 2024, focusing on the innovative field of brachytherapy. Although classified in the Q3 category for Oncology and Q2 for Radiology, Nuclear Medicine, and Imaging based on the 2023 quartile rankings, it continues to make significant contributions to clinical practice and methodology. Brachytherapy holds a respectable position in Scopus, ranking #155/333 and #234/404 in its respective categories, which reflects its importance and relevance to the scientific community. This journal is indispensable for researchers, healthcare professionals, and students looking to stay abreast of the latest techniques and therapeutic approaches in cancer treatment and imaging practices.

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.

Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.